RecruitingPhase 4NCT07022821

Comparison of Dexmedetomidine + Ketamine for Postoperative Pain in C-Section

Comparison of Different Doses of Dexmedetomidine in Combination With Ketamine for Control of Post-Operative Pain in Lower Segment Caesarean Section Surgeries


Sponsor

Fatima Memorial Hospital

Enrollment

90 participants

Start Date

May 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare three different doses of dexmedetomidine, when combined with a fixed dose of ketamine, for pain control in women undergoing cesarean section. The goal is to find the most effective combination with the fewest side effects.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria3

  • Elective lower segment cesarean section
  • American Society of Anesthesiologists (ASA) Physical Status II
  • Provided informed consent

Exclusion Criteria4

  • Known drug allergy
  • Presence of significant comorbidities
  • Emergency surgery
  • Documented psychiatric illness

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

Dexmedetomidine infusion at one of the following doses: Group A: 0.2 µg/kg/hr Group B: 0.3 µg/kg/hr Group C: 0.4 µg/kg/hr Route of Administration: Intravenous Frequency: Continuous infusion during postoperative period

DRUGketamine

Ketamine infusion at a fixed dose of 0.25 mg/kg/hr administered in all three groups. Route of Administration: Intravenous Frequency: Continuous infusion during postoperative period


Locations(1)

Department of Anesthesiology, Fatima Memorial Hospital

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07022821


Related Trials